Phosphorylated MAPK-Erk1/2 activates a variety of target molecules involved in the regulation of cell cycle progression, proliferation, apoptosis, and migration of liver cells, and also other processes crucial to promote the development of liver cancer, such as invasion and metastasis [69]. Here, MAPK3 is linked to liver cancer.